Michael Cavnar, MD
Surgical Oncology · Lexington, KYNPI 1699970426
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,471 of the $1,714 with a category attached, or 85.8%. 10 manufacturers reported payments, led by Intera Oncology, Inc at 34.6% of the total. That places this record below the midpoint for surgical oncology clinicians in KY, where the typical reported total is $2,984.
Across 20 payments — averaging $85.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intera Oncology, Inc$594
- Covidien LP$319
- Angiodynamics, Inc.$177
- GE HealthCare$147
- Genentech USA, Inc.$142
- AstraZeneca$124
- plus $211 from 4 others
What the payments were for
- Travel & lodging$24314%
- Food & beverage$1,47186%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intera Oncology, Inc | 6 | $594 |
| Covidien LP | 4 | $319 |
| Angiodynamics, Inc. | 2 | $177 |
| GE HealthCare | 1 | $147 |
| Genentech USA, Inc. | 1 | $142 |
| AstraZeneca | 1 | $124 |
| Tempus AI, Inc | 2 | $85 |
| BD | 1 | $69 |
| Boston Scientific | 1 | $39 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intera 3000 Implantable Pump$208
- IMFINZI$124
- INTERA$123
- Nanoknife$117
How this compares
$1,714 in reported general payments places this provider in the 40th percentile of 29 surgical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 88 | $335,898 |
| ZenpepLipase/Protease/Amylase | 13 | $51,992 |
| Enoxaparin Sodium | 14 | $2,798 |
| Pantoprazole Sodium | 31 | $238 |
| Metoclopramide Hcl | 26 | $163 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Lexington
- Jennifer WhittingtonLexington$22K
- Prakash PandalaiLexington$8K
- Veronica JonesLexington$4K
- Lawrence ShirleyLexington$3K
- Andrei CocieruLexington$3K
- Irada Ibrahim-ZadaLexington$2K
- Leah WinerLexington$1K
- Sean StokesLexington$849
- Mautin Barry-HundeyinLexington$627
- Patrick McGrathLexington$271
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.